ArticleFrontiers in medicine2026
Amniotic fluid embolism complicated by pulmonary embolism leading to multiple organ dysfunction: case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale: Amniotic fluid embolism (AFE) is a rare and life-threatening obstetric emergency with an extremely high mortality rate. Pulmonary thromboembolism (PTE), a severe comorbidity of AFE in the puerperium, further exacerbates hemodynamic disturbance and multiple organ injury, posing great challenges to clinical diagnosis and targeted intervention. Relevant clinical diagnosis and treatment experience still need to be further supplemented and optimized. Patient concerns: A 37-year-old advanced-age parturient with a history of hysteroscopic adhesiolysis suffered a sudden onset of AFE following forceps-assisted delivery, complicated with PE and severe multiple organ dysfunction. The patient developed acute respiratory failure, cardiogenic shock, and coagulopathy in a short period with critical clinical manifestations, requiring emergent intensive care intervention. Diagnosis: Amniotic fluid embolism complicated with pulmonary embolism and multiple organ dysfunction syndrome (MODS). Interventions: A multidisciplinary team (MDT) formulated and implemented a comprehensive and individualized treatment regimen for the patient: invasive mechanical ventilation was administered for respiratory support; precise volume management guided by pulse indicator continuous cardiac output (PICCO) was adopted, combined with vasoactive agents and inotropic drugs for circulatory support; tranexamic acid (TXA) and component blood transfusion were given to correct coagulopathy, and risk-stratified anticoagulant therapy was promptly initiated after the recovery of coagulation function; standardized anti-infection therapy and preventive measures for thrombotic complications were implemented throughout the entire treatment course. Outcomes: After 72 h of intensive care and dynamic treatment adjustment, the patient's hemodynamic and respiratory status improved significantly and stabilized, and she was successfully weaned from mechanical ventilation. At the 30-day follow-up after discharge, the patient achieved complete recovery of organ function with no long-term sequelae or related complications. Lessons learned: This case indicates that clinicians should maintain a high degree of vigilance for the possibility of complicated PE in AFE patients, especially those with high-risk factors such as advanced age and operative delivery. Early identification via standardized diagnostic tools, seamless collaboration of the MDT, precise organ function support based on real-time monitoring, and dynamic adjustment of the treatment regimen according to the patient's condition are the core keys to improving the success rate of treatment and the prognosis of patients with AFE complicated with PTE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.